JN Macri Technologies Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

JN Macri Technologies General Information

Description

Provider of prenatal screening technology. The company holds and licenses global patents related to free beta Human Chorionic Gonadotropin ("free Beta hCG"). Free Beta hCG is a peptide hormone produced in the early stage of pregnancy that is recognized as a critical biomarker for first-trimester prenatal risk assessment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Biotechnology
Acquirer
Primary Office
  • 403 Oakwood Road
  • Huntington Station, NY 11746
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

JN Macri Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore JN Macri Technologies‘s full profile, request access.

Request a free trial

JN Macri Technologies Patents

JN Macri Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5252489-A Down syndrome screening method utilizing dried blood samples Expired - Lifetime 17-Jan-1989 000000000 0